![Shelcal OS 500mg Calcium with Alfacalcidol Tablets at Rs 206/strip | Osteoporosis Medications in Surat | ID: 26110661455 Shelcal OS 500mg Calcium with Alfacalcidol Tablets at Rs 206/strip | Osteoporosis Medications in Surat | ID: 26110661455](https://5.imimg.com/data5/SELLER/Default/2022/9/PO/HM/RL/101428670/shelcal-os-500mg-calcium-with-alfacalcidol-tablets-1000x1000.jpg)
Shelcal OS 500mg Calcium with Alfacalcidol Tablets at Rs 206/strip | Osteoporosis Medications in Surat | ID: 26110661455
![Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol](https://www.mdpi.com/molecules/molecules-14-03869/article_deploy/html/images/molecules-14-03869-sch001-550.jpg)
Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol
![Table 5 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar Table 5 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2541c720866d0f7409f45328b7e39afe211e66a0/5-Table5-1.png)
Table 5 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar
![PDF) Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: A randomized, crossover trial PDF) Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: A randomized, crossover trial](https://www.researchgate.net/profile/Lori-Wazny/publication/5658269/figure/tbl4/AS:601734858690569@1520476178428/Additional-Secondary-Endpoints_Q320.jpg)
PDF) Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: A randomized, crossover trial
![Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients | SpringerLink Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11255-016-1446-1/MediaObjects/11255_2016_1446_Fig1_HTML.gif)
Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients | SpringerLink
![Table 1 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar Table 1 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2541c720866d0f7409f45328b7e39afe211e66a0/2-Table1-1.png)